AI and rare disease epidemiology: Proceed with caution. Lots of caution.
David Lapidus
Consultant with expertise in commercial epidemiology for rare diseases and orphan drugs
Since you don’t live under a rock, you know that OpenAI, Bing, and Google now offer AI chatbots that use large language models (LLMs) to perform near-miracles of research and conversation. What happens when this type of AI gets applied to the epidemiology of rare diseases?
Some researchers at the NIH took a stab at it. They created an AI tool that processes abstracts in PubMed to summarize the incidence and prevalence of rare diseases. Here’s the paper describing the tool. This could be extremely useful; while Orphanet summarizes the epi of many rare diseases, it only covers diseases which its team of humans have analyzed. The NIH tool, by contrast, will immediately run a fresh analysis on any disease you type into the search box.
This could be a huge time-saver for epidemiologists. If you’re clueless about epi, it could give you the basics about a disease that may have never been reviewed before.
Sometimes.
I tested the tool, and it didn’t perform quite as I hoped. Sometimes it offered obsolete prevalence values instead of the latest (much different) results. Often it failed to cite the actual epi studies, instead pulling numbers from review articles or case studies. It also has some inherent limitations based on its research “universe”: it only analyzes PubMed abstracts. The full text of the articles often contains additional data or essential context, and some articles live in other databases (not PubMed).
My take: it’s useful as a “first step” in an epi analysis (particularly if you’re not used to searching for epi studies), but it’s essential to read the full text of the articles, and also to conduct your own full-scale article search. Without a doubt, the tool will sometimes (often?) give you a useful answer… but you won’t know for sure until you do your own research.
领英推荐
For a more detailed review of the tool’s strengths and weaknesses, take a look at my response here.
So at the moment, AI has limited utility for rare disease epidemiology. But as with all things AI… stay tuned. The big three LLM AIs have already improved in the weeks since their launches, and it’s likely that the NIH team will refine their tool, too.
Important clarification: The AI technology that undergirds the NIH tool is very different from what the big data vendors (IQVIA, Optum, Komodo, etc.) use when they apply “AI” to their administrative data. As an example, a common type of analysis applies algorithms to insurance claims data to identify undiagnosed patients based on their similarities to patients with a confirmed diagnosis. This is a validated method with well understood strengths and weaknesses. The bizarre behaviors of the new LLMs have nothing to do with these analyses.
And speaking of those bizarre behaviors…. Like many of you, I’ve also been experimenting with those big three LLM AI chatbots. One of them did a nice job assembling a vacation itinerary for me. They also had some amusing snafus. (Well, maybe not always “amusing.” But certainly interesting.)
Needless to say, the AIs have a long way to go to earn my trust. And when one of them gave me a vacation itinerary, I double-checked the museum hours myself.
AI-Powered Medical Lab Report Analysis & Chat. Start Your Journey to Better Health Today at labInformer.com
1 年?? Introducing Lab Informer | AI-Powered Medical Lab Report Analysis & Chat. Making sense of medical lab reports can be challenging. How many times have you looked at your lab results and found yourself perplexed, not fully understanding what the numbers and terms mean for your health? That's where Lab Informer steps in. Lab Informer is a groundbreaking platform that uses advanced AI technology to analyze your lab reports. All you need to do is upload a photo, PDF, or screenshot of your report to our website, and our AI takes it from there. Our smart system provides a comprehensive analysis, including probable and rare diagnoses, supported by abnormal values in your lab results. But we go beyond just providing a diagnosis. For each one, we offer a detailed description, personalized health advice, and even potential questions to ask your healthcare provider at your next visit. Plus, your health journey doesn't stop there. With our AI-powered chat feature, you can ask follow-up questions about your lab analysis and get detailed, personalized answers anytime. Visit www.labinformer.com today and start your journey to better understand your health. #LabInformer #HealthTech #AI #HealthData